Each filer's latest filing for M96088105 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| BlackRock, Inc. 13G/A | 6.3% |
10/27/2026
Event 9/30/2026
|
||
|
Toronto Dominion Bank
13G/A
|
5.7% |
11/13/2026
Event 9/30/2026
|
||
| The Toronto-Dominion Bank | 5.7% | |||
| TD Securities Inc. | 0.2% | |||
| Morgan Stanley 13G | 5.4% |
8/6/2025
Event 6/30/2025
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (7) | ||||
| Menora Mivtachim Holdings Ltd 13G/A | 4.99% |
3/17/2025
Event 3/11/2025
|
||
|
Soleus Capital Master Fund, L.P.
13G/A
|
4.7% |
8/5/2025
Event 6/30/2025
|
||
| Soleus Capital Master Fund, L.P. | 4.7% | |||
| Soleus Capital, LLC | 4.7% | |||
| Soleus Capital Group, LLC | 4.7% | |||
| Soleus Capital Management, L.P. | 4.7% | |||
| Soleus GP, LLC | 4.7% | |||
| Guy Levy | 4.7% | |||
|
Paradigm Biocapital Advisors LP
13G/A
|
3.5% |
5/15/2026
Event 3/31/2026
|
||
| Paradigm BioCapital Advisors LP | 3.5% | |||
| Paradigm BioCapital Advisors GP LLC | 3.5% | |||
| Senai Asefaw, M.D. | 3.5% | |||
| Paradigm BioCapital International Fund Ltd. | 3.1% | |||
|
Adage Capital Management, L.P.
13G/A
|
2.8% |
5/12/2025
Event 3/31/2025
|
||
| Adage Capital Management, L.P. | 2.8% | |||
| Robert Atchinson | 2.8% | |||
| Phillip Gross | 2.8% | |||
|
Monograph Capital Holdings Advisors, LLC
13D/A
|
1.9% |
6/9/2025
Event 6/5/2025
|
||
| Monograph Capital Partners I, L.P. | 1.8% | |||
| Monograph Capital Partners I GenPar, LP | 1.8% | |||
| Monograph Capital Holdings Advisors, LLC | 1.8% | |||
| Fred Cohen | 1.9% | |||
| Charles Conn | 1.8% | |||
| Cowen Financial Products LLC 13G/A | 0% |
11/14/2025
Event 9/30/2025
|
||
|
RA Capital Management, L.P.
13G/A
|
0% |
8/14/2025
Event 6/30/2025
|
||
| RA Capital Management, L.P. | 0% | |||
| Peter Kolchinsky | 0% | |||
| Rajeev Shah | 0% | |||
| RA Capital Healthcare Fund, L.P. | 0% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 223 | 40.6 M | $1.73B |
| 2026 Q2 | 191 | 42.4 M | $1.56B |
| 2026 Q1 | 175 | 46.4 M | $835M |
| 2025 Q4 | 170 | 43.7 M | $1.02B |
| 2025 Q3 | 163 | 44.0 M | $877M |
| 2025 Q2 | 154 | 39.8 M | $545M |
| 2025 Q1 | 141 | 41.6 M | $461M |
| 2024 Q4 | 139 | 36.3 M | $386M |
| 2024 Q3 | 129 | 35.1 M | $446M |
| 2024 Q2 | 117 | 38.2 M | $641M |
| 2024 Q1 | 113 | 27.2 M | $407M |
| 2023 Q4 | 107 | 21.4 M | $321M |
| 2023 Q3 | 103 | 17.7 M | $248M |
| 2023 Q2 | 87 | 13.3 M | $138M |
| 2023 Q1 | 68 | 12.5 M | $116M |
| 2022 Q4 | 66 | 13.0 M | $115M |
| 2022 Q3 | 62 | 13.3 M | $111M |
| 2022 Q2 | 66 | 13.4 M | $109M |
| 2022 Q1 | 85 | 14.2 M | $124M |
| 2021 Q4 | 79 | 14.7 M | $140M |
| 2021 Q3 | 94 | 14.1 M | $237M |
| 2021 Q2 | 83 | 14.0 M | $214M |
| 2021 Q1 | 90 | 14.3 M | $279M |
| 2020 Q4 | 83 | 14.5 M | $262M |
| 2020 Q3 | 81 | 15.0 M | $289M |
| 2020 Q2 | 85 | 14.7 M | $382M |
| 2020 Q1 | 80 | 14.0 M | $249M |
| 2019 Q4 | 87 | 14.2 M | $473M |
| 2019 Q3 | 85 | 14.6 M | $347M |
| 2019 Q2 | 85 | 14.7 M | $527M |
| 2019 Q1 | 77 | 13.5 M | $498M |
| 2018 Q4 | 65 | 9.59 M | $413M |
| 2018 Q3 | 72 | 9.95 M | $470M |
| 2018 Q2 | 60 | 9.61 M | $483M |
| 2018 Q1 | 43 | 9.14 M | $454M |
| 2017 Q4 | 41 | 6.84 M | $254M |
| 2017 Q3 | 32 | 4.61 M | $145M |
| 2017 Q2 | 21 | 4.72 M | $85.2M |